ghk-cu administration methods subcutaneous topical Peptide GHK-Cu Peptide Dosing Guide: Skin,

This is the most common administration route for research peptides

where it appears in clinical or off-label use, it does so through compounding channels that federal regulators have since restricted (see legal status below)

However, peptides with little clinical research were on the chopping block due to concerns of impurities and dangerous side effects linked to compounded treatments

This is the fundamental challenge Integrative Peptides must address

This innovative peptide works by disrupting the interaction between FOXO4 and p53 proteins within senescent cells

This product is not intended to diagnose or treat any diseases